Foghorn TherapeuticsFHTX

那斯達克 · USD
6.26
-0.23
(-3.54%)
收盤 08/15 03:59 (UTC+8)
08/15 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.05
  • 0.07
  • 0.08
  • 0.03
  • 0.06
  • 0.08
  • 0.08
  • 0.09
  • 0.03
  • 0.16
icon
  • -12.46
  • 36.40
  • 13.36
  • -63.42
  • 108.40
  • 26.97
  • 7.89
  • 13.42
  • -64.67
  • 391.95
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
16,072
3,267
9,247
8,153
7,557
5,952
2,856
7,808
6,888
5,050
營業成本
----------
營業毛利
16,072
3,267
9,247
8,153
7,557
5,952
2,856
7,808
6,888
5,050
營業費用
24,87724,84033,12526,65428,65428,86526,86131,66033,52033,244
研發費用
18,52318,25922,04620,00221,79221,62620,50824,68923,79725,534
推銷及管理費用
6,3546,5815,1656,6526,8627,2396,3536,9717,3257,710
非經常性項目費用
--5,914-----2,398-
其他營業費用
----------
營業利益
-8,805
-21,573
-23,878
-18,501
-21,097
-22,913
-24,005
-23,852
-26,632
-28,194
其他收入及費用
-1,6982,2142,6523,1614,0794,5024,7303,6533,178
利息費用
----------
稅前純益
-7,191
-19,875
-21,664
-15,849
-17,936
-18,834
-19,503
-19,122
-22,979
-25,016
所得稅
----------
稅後純益
-7,191
-19,875
-21,664
-15,849
-17,936
-18,834
-19,503
-19,122
-22,979
-25,016
基本每股稅後盈餘(元)
-0.10-0.29-0.35-0.25-0.28-0.30-0.23-0.31-0.45-0.59
稀釋每股稅後盈餘(元)
-0.10-0.29-0.34-0.26-0.28-0.30-0.30-0.26-0.43-0.59
基本平均股數(千股)
70629.0069540.0063068.0063029.0062978.0062848.0062987.0062602.0051580.0042428.00
稀釋平均股數(千股)
70629.0069540.0063068.0063029.0062978.0062848.0062987.0062602.0051580.0042428.00
還原基本每股稅後盈餘(元)
-0.10-0.29-0.35-0.25-0.28-0.30-0.23-0.31-0.45-0.59
還原稀釋每股稅後盈餘(元)
-0.10-0.29-0.34-0.26-0.28-0.30-0.30-0.26-0.43-0.59
還原基本平均股數(千股)
70,62969,54063,06863,02962,97862,84862,98762,60251,58042,428
還原稀釋平均股數(千股)
70,62969,54063,06863,02962,97862,84862,98762,60251,58042,428
EBITDA(千元)
-6,961-20,025-21,168-15,353-17,531-18,825-20,311-20,174-22,893-24,735

大家都在看

HOT